Evidence map›Paper›PMID 40894148›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Neurobehavioral Signatures in Overgrowth Intellectual Disability Syndromes: Dissecting Genotype-Phenotype Relationships in the PI3K-AKT-MTOR Pathway.

Aaron D Besterman, Gerhard Hellemann, Irma Gutierrez-Mejia, Dzung C Nguyen, Joshua Sadik, Veronica Gandara, Jonathan A Bernstein, Thomas Frazier, Antonio Y Hardan, Charis Eng and 2 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aaron D BestermanUniversity of California San Diego Department of Psychiatry, Division of Child and Adolescent Psychiatry, San Diego, California, USA.ORCID 0000-0002-8671-1203
Gerhard HellemannDivision of Biostatistics, School of Public Health, University of Alabama, Birmingham, Alabama, USA.
Irma Gutierrez-MejiaUniversity of California Los Angeles, Department of Human Genetics, Los Angeles, California, USA.
Dzung C NguyenUniversity of California Los Angeles, Department of Human Genetics, Los Angeles, California, USA.
Joshua SadikUniversity of California Los Angeles, Department of Anesthesiology, Los Angeles, California, USA.
Veronica GandaraCalifornia Northstate University College of Medicine, Elk Grove, California, USA.
Jonathan A BernsteinDepartment of Pediatrics, Division of Medical Genetics, Stanford University School of Medicine, Stanford, California, USA.
Thomas FrazierAutism Speaks.
Antonio Y HardanStanford University School of Medicine, Stanford, California, United States of America.
Charis EngGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Mustafa SahinDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-7044-2953
Julian A Martinez-AgostoUniversity of California Los Angeles, Department of Human Genetics, Los Angeles, California, USA.

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Michal Kouril · 2019 to 2026
$51.2M
Toward better characterization and clinical trial readiness for targeting neuropsychiatric manifestations in PTEN pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI Darcy Krueger · 2014 to 2026
$20.1M
UCLA Medical Genetics Training ProgramT32GM008243 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Julian Martinez-Agosto, STANLEY F. NELSON · 1987 to 2026
$6.8M
NCATS NIH HHS U2C TR002818NIGMS NIH HHS T32 GM008243NINDS NIH HHS U54 NS092090
6 · The paper itself

Abstract

Overgrowth intellectual disability syndromes (OGIDs) caused by mutations in the PI3K-AKT-MTOR pathway present significant neurobehavioral challenges. While PTEN Hamartoma Tumor Syndrome (PHTS) has been behaviorally characterized, Smith-Kingsmore Syndrome (SKS) has not, limiting our understanding of shared and unique features across OGIDs. We conducted comprehensive neurobehavioral assessments in 17 individuals with SKS and compared them to previously characterized cohorts with PHTS (n=74), macrocephaly-associated autism (n=33), and healthy controls (n=32). Assessments included standardized measures of motor coordination, adaptive functioning, social interaction, and executive functioning. We performed genotype-phenotype correlation analyses and developed diagnostic classification models using recursive partitioning. Individuals with SKS showed significant impairments across multiple domains compared to controls. Compared to the PTEN-ASD group, SKS individuals demonstrated particularly severe deficits in motor coordination and adaptive functioning, while executive functioning and behavioral regulation were similarly impaired. Novel clinical features were identified, including immune dysregulation and chronic constipation in SKS, and notably high rates of neonatal teeth (44.7%) in PHTS. Diagnostic classification models incorporating both behavioral and medical features achieved above-chance accuracy in distinguishing between conditions, with neonatal teeth emerging as a key distinguishing feature for PHTS. Domain-specific analyses showed variants in the PTEN phosphatase domain were associated with more severe social and executive function deficits compared to C2 domain variants. Correlation analyses between variant pathogenicity scores and clinical measures revealed limited consistent associations, though Combined Annotation Dependent Depletion (CADD) scores showed stable correlations with sensory processing measures across cohorts. Our findings establish distinct neurobehavioral profiles between SKS and PHTS, suggesting different impacts of MTOR versus PTEN mutations on neural circuit development. The identification of novel phenotypic features expands the clinical spectrum of these disorders and provides new diagnostic markers. The limited predictive value of variant pathogenicity scores for neurobehavioral outcomes emphasizes the need for comprehensive individual assessments. These results provide a foundation for developing targeted interventions while highlighting the complexity of genotype-phenotype relationships in PI3K-AKT-MTOR pathway disorders.

Indexed as

Genotype-phenotype correlationIntellectual disabilityNeurobehavioral phenotypeNeurodevelopmental disordersOvergrowth

Identifiers

PMID40894148
PMCPMC12393652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.